DAW-2020
N/A
Report date: 2022/11/21 10:52:54
NME
Base Information
Drug NameDAW-2020
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Brigham and Women's Hospital
China Registration ClassN/A
Develop Information
Active CompaniesThe Brigham and Women's Hospital
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A